These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 27824000

  • 1. Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters.
    Guo FP, Li YJ, Qiu ZF, Lv W, Han Y, Xie J, Li YL, Song XJ, Du SS, Mehraj V, Li TS, Routy JP.
    Chin Med J (Engl); 2016 Nov 20; 129(22):2683-2690. PubMed ID: 27824000
    [Abstract] [Full Text] [Related]

  • 2. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment.
    Hua W, Jiao Y, Zhang H, Zhang T, Chen D, Zhang Y, Chen X, Wu H.
    Immunol Invest; 2012 Nov 20; 41(1):1-14. PubMed ID: 21563924
    [Abstract] [Full Text] [Related]

  • 3. Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART.
    Ruiz-Mateos E, de la Rosa R, Soriano N, Martinez-Moya M, Rubio A, Sánchez-Quijano A, Lissen E, Leal M.
    Antivir Ther; 2003 Aug 20; 8(4):289-94. PubMed ID: 14518697
    [Abstract] [Full Text] [Related]

  • 4. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M, Shafer LA, Chan S, Kasper K, Keynan Y.
    J Infect Public Health; 2018 Aug 20; 11(2):265-269. PubMed ID: 28826735
    [Abstract] [Full Text] [Related]

  • 5. The predictive role of CD4+ cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: an eight-year observation in China.
    Li CX, Li YY, He LP, Kou J, Bai JS, Liu J, Tian B, Cao LJ, Wang KH, Kuang YQ.
    BMC Immunol; 2019 Aug 28; 20(1):31. PubMed ID: 31455209
    [Abstract] [Full Text] [Related]

  • 6. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E, Coureau G, Guedj J, Blanco P, Pellegrin I, Commenges D, Dabis F, Moreau JF, Pellegrin JL, Thiébaut R, ANRS Co3 Aquitaine Cohort.
    Antivir Ther; 2006 Aug 28; 11(3):343-50. PubMed ID: 16759051
    [Abstract] [Full Text] [Related]

  • 7. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R, Yang Y, Mildvan D, Evans SR, Schnizlein-Bick CT, Hafner R, Webb N, Basar M, Zackin R, Jacobson MA.
    J Clin Immunol; 2005 Mar 28; 25(2):106-15. PubMed ID: 15821887
    [Abstract] [Full Text] [Related]

  • 8. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ, Begovac J, Vince A.
    FEMS Immunol Med Microbiol; 2006 Apr 28; 46(3):351-9. PubMed ID: 16553807
    [Abstract] [Full Text] [Related]

  • 9. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D, Legesse D, Kebede Y, Siraj DS, McBride JA, Striker R.
    PLoS One; 2020 Apr 28; 15(10):e0240880. PubMed ID: 33091053
    [Abstract] [Full Text] [Related]

  • 10. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.
    J Infect Dis; 2006 Jul 01; 194(1):29-37. PubMed ID: 16741879
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status.
    van Rossum AM, Scherpbier HJ, van Lochem EG, Pakker NG, Slieker WA, Wolthers KC, Roos MT, Kuijpers JH, Hooijkaas H, Hartwig NG, Geelen SP, Wolfs TF, Lange JM, Miedema F, de Groot R, Dutch Study Group for Children with HIV Infections.
    AIDS; 2001 Nov 23; 15(17):2267-75. PubMed ID: 11698700
    [Abstract] [Full Text] [Related]

  • 12. Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial.
    Soria A, Trabattoni D, Squillace N, Rainone V, Gnudi F, Clerici M, Gori A, Bandera A.
    PLoS One; 2015 Nov 23; 10(2):e0117118. PubMed ID: 25671649
    [Abstract] [Full Text] [Related]

  • 13. Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders.
    Fan L, Hu Y, Li R, Ding J, Liu Y, Yu S, Hu M, Su R, Li Y, Yu A, Xie D, Zhao Q, Ma P.
    Front Cell Infect Microbiol; 2024 Nov 23; 14():1397743. PubMed ID: 38975330
    [Abstract] [Full Text] [Related]

  • 14. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
    Ndumbi P, Gillis J, Raboud J, Cooper C, Hogg RS, Montaner JS, Burchell AN, Loutfy MR, Machouf N, Klein MB, Tsoukas C, Canadian Observational Cohort (CANOC) Collaboration.
    HIV Med; 2014 Mar 23; 15(3):153-64. PubMed ID: 24304582
    [Abstract] [Full Text] [Related]

  • 15. The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients.
    Lu L, Li X, Liu X, Qiu Z, Han Y, Song X, Li Y, Li X, Cao W, Lv W, Dou Z, Li T.
    Aging (Albany NY); 2022 Dec 09; 14(23):9647-9667. PubMed ID: 36490352
    [Abstract] [Full Text] [Related]

  • 16. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
    Li T, Wu N, Dai Y, Qiu Z, Han Y, Xie J, Zhu T, Li Y.
    Clin Infect Dis; 2011 Nov 09; 53(9):944-51. PubMed ID: 21960716
    [Abstract] [Full Text] [Related]

  • 17. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
    Rallón N, Sempere-Ortells JM, Soriano V, Benito JM.
    J Antimicrob Chemother; 2013 Nov 09; 68(11):2616-25. PubMed ID: 23833186
    [Abstract] [Full Text] [Related]

  • 18. Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study.
    Bordoni V, Brando B, Piselli P, Forini O, Perna FE, Atripaldi U, Carputo S, Garziano F, Trento E, D'Agosto G, Latini A, Colafigli M, Cristaudo A, Sacchi A, Andreoni M, De Carli G, Orchi N, Grelli S, Gatti A, Cerva C, Minutolo A, Potestà M, Di Martino ML, Ortu F, Selva P, Del Pup L, Guarnori I, Lorenzini P, Capuano G, Antinori A, Agrati C.
    PLoS One; 2019 Nov 09; 14(12):e0225415. PubMed ID: 31869342
    [Abstract] [Full Text] [Related]

  • 19. Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
    Di Mascio M, Sereti I, Matthews LT, Natarajan V, Adelsberger J, Lempicki R, Yoder C, Jones E, Chow C, Metcalf JA, Sidorov IA, Dimitrov DS, Polis MA, Kovacs JA.
    J Virol; 2006 Mar 09; 80(6):2665-74. PubMed ID: 16501076
    [Abstract] [Full Text] [Related]

  • 20. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.
    Mehandru S, Poles MA, Tenner-Racz K, Jean-Pierre P, Manuelli V, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M.
    PLoS Med; 2006 Dec 09; 3(12):e484. PubMed ID: 17147468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.